Acute Renal Failure Post High Dose Methotrexate Infusion Successfully Managed with High Dose Folinic Acid and High Flux Dialysis

被引：0
作者：
Suthanthira Kannan Ramamoorthy
R. Hephziba
机构：
[1] C Block,
[2] VNCC,undefined
[3] G Kuppusamy Naidu Memorial Hospital,undefined
来源：
Indian Journal of Hematology and Blood Transfusion | 2013年 / 29卷
关键词：
Interstitial Nephritis; High Dose Methotrexate; MTHFR Gene; Reduce Folate Carrier; Methotrexate Toxicity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
High dose methotrexate infusion has become the standard of care in pediatric and adult acute lymphoblastic leukemia management. Adequate hydration, alkalinization of urine and optimal folinic acid rescue are the key factors in the prevention of toxicity. The development of acute renal failure after high dose methotrexate infusion is very rare, albeit a few cases have been reported in literature. Various options have been available in addition to high dose folinic acid rescue, such as ultra filtration dialysis, continuous extracorporeal therapy, thymidine and Glucarpidase infusion to directly counter act excess methotrexate. In a developing country with limited reserves, managing a patient who develops acute renal failure immediately after high dose methotrexate is a nightmare without Glucarpidase. We report here a case that has been managed successfully with intensive supportive measures alone.
引用
收藏
页码：90 / 92
页数：2
相关论文
共 46 条
  • [1] Zimmermann M(2008)Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL BFM 95 Blood 111 4477-4489
  • [2] Gadner H(2010)Treatment of methotrexate intoxication with various modalities of continuous extracorporeal therapy and glucarpidase Pharmacotherapy 30 111-1019
  • [3] Stanulla M(2007)Successful high-dose methotrexate chemotherapy in a patient with acute lymphocytic leukemia who developed acute renal failure during the initial treatment Pediatr Int 49 1018-e316
  • [4] Dordelmann M(2010)Reduced methotrexate clearance and renal impairment in a boy with osteosarcoma and earlier undetected autosomal dominant polycystic kidney disease (ADPKD) Pediatr Hematol Oncol 32 e314-156
  • [5] Niethammer D(2008)Renal failure after high-dose methotrexate in a child homozygous for MTHFR C677T polymorphism Pediatr Blood Cancer 50 154-1552
  • [6] Riehm H(1978)Comparative effects of citrovorum factor and carboxypeptidase G1 on cerebrospinal fluid-methotrexate pharmacokinetics Cancer Treat Rep 62 1549-4436
  • [7] Schrappe M(2008)High-dose methotrexate in osteosarcoma: let the questions surcease—time for final acceptance J Clin Oncol 26 4365-703
  • [8] Vilay AM(2006)Understanding and managing methotrexate nephrotoxicity Oncol 11 694-2232
  • [9] Mueller BA(2004)High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma incidence Treat Outcome Cancer 100 2222-undefined
  • [10] Haines H(undefined)undefined undefined undefined undefined-undefined
12345